Question 1

What is CereVasc?

Accepted Answer

CereVasc is a Entity.

Question 2

How often does CereVasc appear in global news?

Accepted Answer

Tracked across 1 news events drawn from 6 articles.

Question 3

When was CereVasc first tracked by Ergen?

Accepted Answer

First tracked on Jun 04, 2026.

Question 4

When was CereVasc last mentioned in news?

Accepted Answer

Last active on Jun 04, 2026.

Question 5

What is CereVasc's current news sentiment?

Accepted Answer

Aggregate sentiment score: 75 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is CereVasc in global news coverage?

Accepted Answer

Attention score of 4, derived from article volume and coverage intensity across 1 events.

Question 7

What is the most recent event involving CereVasc?

Accepted Answer

CereVasc secures $85M Series C (Jun 04, 2026, 6 articles).

Question 8

How did the "CereVasc secures $85M Series C" event impact CereVasc?

Accepted Answer

CereVasc successfully completed an $85 million Series C financing, which will fund the continued clinical and regulatory development of its eShunt System, including the STRIDE pivotal trial, and preparations for US commercialization. This financing significantly advances the company's growth and product development.

Question 9

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.